Concepedia

Fayang Ma

FM

Statistics

Publications

9

Citations

311

H-Index

9

Active since

2017

Affiliations

China-US (Henan) Hormel Cancer Institute(Current)

Zhengzhou University

Henan Cancer Hospital

University of Minnesota

Hormel (United States)

Fayang Ma is an author at China-US (Henan) Hormel Cancer Institute specializing in medicine, oncology, and molecular oncology.

Publications per year

2017–2022

9

Publications

9

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

Tingxuan Gu, Simin Zhao, Guoguo Jin et al. · Frontiers in Immunology · 2021 · 90 citations · Full text

, , +17

3,3'-Diindolylmethane inhibits patient-derived xenograft colon tumor growth by targeting COX1/2 and ERK1/2

Xueli Tian, Kangdong Liu, Xueyin Zu et al. · Cancer Letters · 2019 · 40 citations

, , +8

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma

Fangfang Liu, Qiong Wu, Wei Han et al. · Clinical and Translational Medicine · 2021 · 38 citations · Full text

, , +17

The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations

Fayang Ma, Kyle Vaughn Laster, Zigang Dong · Nature Communications · 2022 · 33 citations · Full text

, , +15

Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC

Dong Joon Kim, Mee‐Hyun Lee, Kangdong Liu et al. · Carcinogenesis · 2017 · 32 citations · Full text

, , +14

1–5 of 9